Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b-Reference-Cited by-同舟云学术

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

Published:2020-08 Issue:2 Volume:56 Page:106052
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Hong Sun In,Ryu Byung-Han,Chong Yong Pil^ORCID,Lee Seungjun^ORCID,Kim Sunjoo,Kim Ho Cheol,Hong Kyung-Wook,Bae In-Gyu,Cho Oh-Hyun

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 [https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020]

2. COVID-19: combining antiviral and anti-inflammatory treatments;Stebbing;Lancet Infect Dis,2020

3. COVID-19 in 2 Persons with Mild Upper Respiratory Tract Symptoms on a Cruise Ship, Japan;Arashiro;Emerg Infect Dis.,2020

4. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China;Wu;JAMA Intern Med.,2020

5. Early Short Course Corticosteroids in Hospitalized Patients With COVID-19;Fadel;Clin Infect Dis,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval;Drug Design, Development and Therapy;2022-03

2. SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses;Future Microbiology;2021-09

3. Multiple sclerosis immunomodulatory therapies tested for effectiveness in COVID-19;Neurologia i Neurochirurgia Polska;2021-08-31

4. Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β;Journal of Clinical Immunology;2021-06-08

5. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options;Pharmaceuticals;2021-05-28